Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

The PIRL laser cuts tissue with less damage and scarring than traditional methods.

PLLA injections can cause hair loss and skin issues.

Bisphenol-A (BPA) increases connections between brain cells and boosts their activity, but it blocks the effects of a male hormone on brain cell plasticity.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The new controlled release PRP therapy shows promise for hair growth in women.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Certain alkaloids could help create new coronavirus drugs.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.